Prevacid and Nutropin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prevacid (lansoprazole) and Nutropin (somatropin [rdna origin]). Common drug interactions include hyperphagia among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Prevacid and Nutropin. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Prevacid?

Prevacid has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 130,714 Prevacid users. Check the latest studies of Prevacid.

What is Nutropin?

Nutropin has active ingredients of somatropin [rdna origin]. eHealthMe is studying from 4,799 Nutropin users. Check the latest studies of Nutropin.

On Aug, 10, 2026

26 people who take Prevacid and Nutropin together, and have interactions are studied.

Prevacid and Nutropin drug interactions.

What are the common drug interactions of Prevacid and Nutropin, by gender? *:

female:

Hyperphagia (an abnormal appetite for food)
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
Pathological gambling
Therapeutic response decreased (less preventive response)
Contusion (a type of hematoma of tissue in which capillaries)
Diarrhoea
Epstein-barr virus infection
Fatigue (feeling of tiredness)
Hypercholesterolaemia (high levels of cholesterol in the blood)
Hyperlipidaemia (presence of excess lipids in the blood)

male:

Pain
Abdominal pain
Injection site discolouration
Osteochondroma (a type of benign tumour that consists of cartilage and bone)
Anxiety
Arthropathy
Ataxia (loss of full control of bodily movements)
Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
Cystic fibrosis (disease of the secretary glands)
Decreased appetite

What are the common drug interactions of Prevacid and Nutropin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Headache (pain in head)
Death
Disease recurrence
Heart rate increased
High density lipoprotein decreased
Low density lipoprotein increased (cholesterol increased in blood)
Neoplasm recurrence (reoccurrence of tumour)
Pain
Pneumonia
Tremor (trembling or shaking movements in one or more parts of your body)

10-19:

Abdominal pain
Chronic kidney disease
Epiphysiolysis
Growth retardation (delayed growth)
Pain
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
Upper respiratory tract infection
Cystic fibrosis (disease of the secretary glands)
Hyperglycaemia (high blood sugar)
Insulin resistance

20-29:

n/a

30-39:

Injection site discolouration

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Growth Hormone Deficiency: 9 people, 34.62%
Chronic Kidney Disease: 6 people, 23.08%
Hypersensitivity: 3 people, 11.54%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 7.69%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 7.69%
Drowsiness: 2 people, 7.69%
Fat Intolerance (inability to use fat by digestive system): 2 people, 7.69%
Head Injury: 2 people, 7.69%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 2 people, 7.69%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Prevacid and Nutropin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously